Otofonix Helix vs RxEars Rxi

The Otofonix Helix is a behind-the-ear amplification product released in 2021, priced at $695. In HearAdvisor's lab testing, it earned a C grade with a SoundScore of 2.6/5, ranking #7 of 8 devices in the Amplification Product category. The Helix demonstrates one clear strength: excellent feedback handling at 5.0/5, which is 0.72 points above the category average. This means users are unlikely to experience whistling or squealing during typical use. However, the device shows significant limitations in other areas. Speech clarity scores are low in both quiet (1.0/5) and noisy (1.0/5) environments, falling below category averages by 1.11 and 0.37 points respectively. Own-voice comfort is notably weak at 0.3/5 in the tuned configuration, measuring 2.34 points below the category average. This suggests users may find their own voice sounds unnatural or boomy. Music streaming capability scored 0.0/5, indicating this device is not suitable for those who want to stream audio content. Consumers in this price range have substantially higher-performing alternatives available. The Sennheiser Conversation Clear Plus scores 4.04/5, while the HearingAssist Micro achieves 3.54/5. Those seeking similar performance at a lower price point might consider the Otofonix Encore or RCA Micro. The Helix may appeal to users who prioritize feedback-free amplification over speech clarity or streaming features, but most shoppers will find better value elsewhere in this category.

The RxEars Rxi is a budget-priced prescription hearing aid in an invisible-in-ear style, earning an A grade with a SoundScore of 4.1/5 in our lab testing. At $499, it ranks #24 of 39 prescription hearing aids tested, placing it in the top 59% of its category. This device demonstrates notable strengths in speech understanding in quiet environments, scoring 4.3/5—a strong result that sits 0.89 points above the category average of 3.40/5. Feedback handling is excellent at 4.7/5, providing stable performance during movement without the whistling that can plague some hearing aids. Speech in noise performance is mixed at 2.1/5, essentially matching the category average. The RxEars Rxi has significant limitations to consider. Own-voice comfort scores low at 1.6/5, falling 1.10 points below the category average—users may notice their own voice sounds unnatural or boomy. Music streaming is not supported, scoring 0.0/5, which is 2.76 points below the category average. This device uses disposable batteries rather than rechargeables. The RxEars Rxi is best suited for users who prioritize discreet cosmetics and clear speech understanding in quieter settings, and who don't need music streaming capabilities. Those sensitive to own-voice quality or who frequently listen to streamed audio should explore alternatives.